mozavaptan has been researched along with gemcitabine in 1 studies
| Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (gemcitabine) | Trials (gemcitabine) | Recent Studies (post-2010) (gemcitabine) |
|---|---|---|---|---|---|
| 165 | 8 | 24 | 12,523 | 3,208 | 6,923 |
| Protein | Taxonomy | mozavaptan (IC50) | gemcitabine (IC50) |
|---|---|---|---|
| Chain A, DEOXYNUCLEOSIDE KINASE | Drosophila melanogaster (fruit fly) | 0.76 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, K; Tamura, T | 1 |
1 other study(ies) available for mozavaptan and gemcitabine
| Article | Year |
|---|---|
Small cell gall bladder carcinoma complicated by syndrome of inappropriate secretion of antidiuretic hormone (SIADH) treated with mozavaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Antimetabolites, Antineoplastic; Benzazepines; Carcinoma, Small Cell; Deoxycytidine; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Inappropriate ADH Syndrome; Middle Aged; Treatment Outcome | 2013 |